Delivery Order SPE2DB20D3101-SPE2DB23FRYN6

Award Date 9/21/23
Potential Completion Date 9/22/23
Potential Value $336
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $27,980 to Amerisourcebergen Drug Corporation. The order is for 500 tablets of the generic cholesterol medication atorvastatin 20 mg. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with delivery required between August 24-25, 2023. The Defense Logistics Agency routinely procures pharmaceuticals and other medical supplies to support Department of Defense personnel...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $728 to Amerisourcebergen Drug Corporation for the supply of 80mg atorvastatin tablets. As the prime contractor, Amerisourcebergen will deliver 30-count bottles of the cholesterol-lowering medication to a facility in Conshohocken, Pennsylvania, with performance required between August 11-14, 2023. The order was placed under an existing DLA contract vehicle in support of the agency's medical supply...
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $336 to Amerisourcebergen Drug Corporation for the supply of 500 tablets of 20mg atorvastatin. As the prime contractor, Amerisourcebergen will deliver the generic cholesterol-lowering medication to a facility in Conshohocken, Pennsylvania under a contract spanning from August 28 to 29, 2023. No subcontractors or set aside designations were indicated. The Defense Logistics Agency functions to support military...
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $80,920 to Amerisourcebergen Drug Corporation to supply 500 boxes of 20mg atorvastatin tablets. As the prime contractor, Amerisourcebergen will deliver the generic cholesterol-lowering medication to a facility in Conshohocken, Pennsylvania by August 23, 2023 under the terms of the contract. The order was placed utilizing Amerisourcebergen's Federal Supply Schedule pharmaceutical distribution contract with the DLA,...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $83,940 to Amerisourcebergen Drug Corporation to supply 500 tablets of the generic cholesterol medication atorvastatin. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to a facility in Conshohocken, Pennsylvania under a schedule starting on August 15, 2023 and concluding on August 16, 2023. The order was placed against an existing DLA contract vehicle to support the agency's...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $83,940 to Amerisourcebergen Drug Corporation. The order is for 500 tablets of the generic cholesterol medication atorvastatin 20 mg. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with delivery required between August 29-30, 2023. The Defense Logistics Agency routinely issues such orders under its Prime Vendor program to support the medical supply needs of the U.S....
The Defense Logistics Agency, a combat logistics support agency within the Department of Defense, awarded a $503,640 firm fixed price delivery order to AmerisourceBergen Drug Corporation for 500 bottles of 20mg atorvastatin tablets. The place of performance is AmerisourceBergen's corporate office and distribution center located in Conshohocken, Pennsylvania. The order is to be completed between July 13-14, 2023. No major subcontractors or set aside designations were identified. The delivery...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at seventy-four thousand six hundred and sixty-four dollars to Amerisourcebergen Drug Corporation for the supply of atorvastatin tablets. Under the contract, Amerisourcebergen will deliver four hundred and fifty-six thousand two hundred and three tablets of atorvastatin, an 80mg cholesterol-lowering medication, to a facility in Conshohocken, Pennsylvania within a performance period spanning September 1st through...
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $242.76 to Amerisourcebergen Drug Corp for the supply of 1,000 tablets of 40mg atorvastatin. The order is to be performed in Conshohocken, Pennsylvania by July 24, 2023, with the Defense Logistics Agency as the funding agency. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corp, which will serve as the prime contractor to fulfill this order for the generic cholesterol medication. No...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $404.60 to Amerisourcebergen Drug Corp for the supply of 1000 tablets of 40mg atorvastatin. As the prime contractor, Amerisourcebergen Drug Corp will deliver the generic cholesterol-lowering medication from its Conshohocken, Pennsylvania facility to support the Defense Logistics Agency's medical supply needs. No subcontractors or set aside designations were indicated. The delivery order was issued on August 24, 2023...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB23FRYN6
    Delivery Order

The Defense Logistics Agency awarded a firm fixed price delivery order valued at $336 to Amerisourcebergen Drug Corporation for the supply of 500 tablets of 20mg atorvastatin. As the prime contractor, Amerisourcebergen will deliver the generic cholesterol-lowering medication to a facility in Conshohocken, Pennsylvania under a one-day period of performance beginning September 21, 2023. The order is placed against an existing DLA contract vehicle to support the agency's procurement of pharmaceuticals for military treatment facilities and beneficiaries. No subcontractors or set aside designations were indicated.

Generated 12/21/23, 10:17 AM